Skip to content
Open access

Isoflavones with Multifaceted Activities Synergistically Sensitize Pseudomonas aeruginosa to Antibiotics In Vitro and In Vivo

Aug 2026 · Antibiotics · Vol 15 · 0 citations · 38 references
Medicine

TL;DR

Daidzein and genistein serve as effective adjuncts to conventional antibiotics, exerting multifaceted actions against P. aeruginosa infection, implying a protective effect on host tissues through PPAR-γ activation.

Abstract

Background/Objectives: Pseudomonas aeruginosa is a notorious multidrug-resistant pathogen that causes serious acute and chronic infections by employing quorum sensing (QS)-regulated virulence, biofilm formation, and host-damaging inflammation. To overcome the yield limitation of two previously identified marine secondary metabolites with dual QS inhibitory and PPAR-γ agonistic activities, we further screened marine-derived natural products for more abundant candidates with similar anti-virulence and anti-inflammatory properties. Methods: In this study, isoflavones were evaluated for anti-QS and PPAR-γ transactivation activities using reporter gene assays, and for antibacterial, anti-virulence, and anti-inflammatory effects via broth microdilution, biofilm, G. mellonella infection, and ELISA cytokine assays. Results: Daidzein and genistein were selected for their optimal anti-QS and PPAR-γ activation activities. They inhibited a key QS regulator and suppressed pyocyanin production and biofilm formation in P. aeruginosa without affecting bacterial growth, indicating minimal selective pressure for resistance. In addition, daidzein and genistein were found to synergistically sensitize the wild-type P. aeruginosa strain to gentamicin, carbenicillin, tobramycin, ampicillin, and polymyxin B, and synergistically or partially synergistically sensitize a multidrug-resistant strain to gentamicin, tobramycin, and ampicillin. Moreover, a Galleria mellonella infection model confirmed that daidzein and genistein significantly enhance the efficacy of gentamicin against P. aeruginosa infection in vivo. Furthermore, in host macrophages, daidzein and genistein significantly inhibited LPS-induced production of NO, IL-6, and IL-1β when combined with an RXR agonist, implying a protective effect on host tissues through PPAR-γ activation. Conclusions: These findings demonstrate that daidzein and genistein serve as effective adjuncts to conventional antibiotics, exerting multifaceted actions against P. aeruginosa infection.

Read PDF

Similar papers

Open access Sep 2026

Mechanisms of synergistic antibacterial and anti-biofilm effects of dihydroquercetin combined with ceftazidime against mucoid pseudomonas aeruginosa

Objective This study characterized the synergistic activity of dihydroquercetin combined with ceftazidime (CAZ) against mucoid Pseudomonas aeruginosa (mPA). The regimen primarily relieves biofilm-mediated phenotypic tolerance in CAZ-susceptible isolates, rather than reversing classical genetic resistance, while also en...

Li Gao, Wen-Jun Lu, Ke-Da Chen et al. · 0 citations
Open access Aug 2026

A quorum sensing antagonist with dual bacterium- and host-directed anti-pathogenic activity against Pseudomonas aeruginosa

It is demonstrated that Spongosorites sp-derived bisindole alkaloid (R)-6’-debromohamacanthin B (RDB) exerts dual bacterium-directed and host-directed activities, simultaneously attenuating virulence and biofilm formation while reinforcing host defense and controlling pathological inflammation.

Dan-Dan Li, Hui-Yan Li, Wen-Bo Niu et al. · 0 citations
Open access Oct 2026

4-Hydroxycoumarin inhibits biofilm formation and enhances antibiotic efficacy against Escherichia coli O157:H7

Background Conventional bactericidal antibiotics often fail to eradicate Escherichia coli O157:H7 (E. coli O157) infections due to biofilm-mediated antimicrobial tolerance, and monotherapy can inadvertently drive resistance selection. This study aimed to identify compounds capable of modulating LuxS/AI-2-related phenot...

Hong-Xing Zhang, Jing Xu, Ya-Xin Zhou et al. · 0 citations
Aug 2026

Evaluation of phytochemical-mediated inhibition of the efflux pump in Pseudomonas aeruginosa PAO1

Results position Salvianolic acid A and the other phytochemicals evaluated here as promising adjuvant candidates for tackling multidrug-resistant Pseudomonas aeruginosa, and warrant their continued investigation as adjunctive therapeutic options alongside conventional antibiotics.

Adarsha Sarmah, Aanand Kumar, Anto Antony Selvaraj et al. · 0 citations
Review Sep 2026

Quorum Sensing and Biofilm Formation: Emerging Targets of Mushroom-Derived Antimicrobials

The potential of mushrooms as a source of novel QSIs is discussed, as reflected in their diverse bioactive compounds, multidirectional mechanisms of action, species-specific activity, and synergistic interaction with conventional antibiotics.

S. C. Karunarathna, Wen-Hua Lu, N. Patabendige et al. · 0 citations
Review Open access Aug 2026

Beyond probiotics: Lacticaseibacillus rhamnosus as a multi-target antagonist of Pseudomonas aeruginosa infections.

Findings support the potential role of L. rhamnosus as an adjunctive strategy in the management of P. aeruginosa infections, while highlighting the need for mechanistic standardization and clinical validation.

W. R. S. Gomes, Gessiane Dos Santos Souza, João Inácio Diniz Ferreira et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.